PHC Holdings Corporation
About Us
Group Companies
Products & Services
CSR
Investor Relations
About Us
Corporate Overview
History
Mission Vision Values
Value Creation Plan
Leadership
Group Companies
Ascensia Diabetes Care Holdings AG
Epredia Holdings Ltd.
PHCbi
Medicom
LSI Medience
Products & Services
Cancer Pathology
Biologic & Cell Preservation
Diagnostic Testing
Patient Record & Billing Software
Diabetes Management
Medical Device & Drug Delivery
CSR
CORPORATE INTEGRITY
Code of Conduct
Corporate Governance
Risk Management
Information Security
CSR Procurement
Developing Quality Products
Customer Satisfaction
PEOPLE INSIGHTS
Human Rights Policy
Promoting Diversity
Work Style Reform
Developing Human Resources
Creating a Safe & Healthy Workplace
ENVIRONMENTAL SUSTAINABILITY
Environmental Activities
SOCIAL RESPONSIBILITY
Solving Problems through Business
Regional Social Action Programs
COVID-19 Response
Investor Relations
INVESTOR RELATIONS
MANAGEMENT
Corporate Governance
IR Basic Policy
IR LIBRARY
Financial Results
Presentation Materials
IR Materials
Mid-term Plan
STOCK INFORMATION
Stock Overview
General Meeting of Shareholders
Stock Quotations
IR News
Financial Highlights
IR Calendar
Contact IR
Disclaimer
Newsroom
Careers
Contact
JP
Other PHC Group Websites
PHC Corporation
Ascensia Diabetes Care Holdings AG
Epredia Holdings Ltd.
LSI Medience Corporation
PT PHC Indonesia
PHC Corporation of North America
PHC Europe B.V.
PHC Medicom Corporation
PHC Corporation (Shanghai) Ltd.
SciMed (ASIA) Pte Ltd
Amelieff Corporation
Other PHC Group Websites
PHC Corporation
Ascensia Diabetes Care Holdings AG
Epredia Holdings Ltd.
LSI Medience Corporation
PT PHC Indonesia
PHC Corporation of North America
PHC Europe B.V.
PHC Medicom Corporation
PHC Corporation (Shanghai) Ltd.
SciMed (ASIA) Pte Ltd
Amelieff Corporation
Newsroom
Careers
Contact
JP
Newsroom
>
2022
News
2022
Select year
2023
2022
2021
2020
2019
2018
2017
2016
2015
PHC Holdings Corporation
Group Companies
Dec.2
News
Announcement of Resignation and Change in Role of Corporate Officer at PHC Holdings Corporation
Dec.1
News
Announcement of New Assignment of Corporate Officer at PHC Holdings Corporation Effective January 1, 2023
Nov.16
News
PHC Group Releases Newly Revised Mid-Term Plan, the "Value Creation Plan," Outlining Changes for FY2025 to Accelerate Growth by Advancing Value-Based Healthcare
Nov.16
IR
Notice of establishment of a new company and the integration (company split/absorption-type merger) of Medical Information Systems (Medicom) Business Unit, PHC Corporation and PHC Medicom Corporation which are wholly-owned subsidiaries of PHC Holdings Corporation
Sep.1
News
Announcement of Changes in Corporate Officer Area of Responsibility at PHC Holdings Corporation Effective September 1, 2022
Aug.12
News
Announcement of Resignation of Corporate Officer at PHC Holdings Corporation and New Assignment at PHC Group Subsidiary
Jun.29
News
Announcement of Changes in Board Members and Audit and Supervisory Board Member at PHC Holdings Corporation Effective June 29 and July 1, 2022
Jun.13
News
Announcement of Changes in Corporate Officers at PHC Holdings Corporation Effective June 13 and July 1, 2022
Jun.13
News
Announcement of Resignation of a Corporate Officer at PHC Holdings Corporation Effective June 1, 2022
May.25
IR
Notice regarding the Early Retirement Program at PHC Holdings Corporation and the consolidated subsidiaries
May.25
News
Announcement of Changes to Board of Directors at PHC Holdings Corporation Effective June 29 and July 1
May.12
IR
PHC Holdings Corporation Announces FY21 Full-Year Results and FY22 Forecast
Apr.28
News
PHC Holdings Corporation Appoints Shoji Miyazaki as Chief Executive Officer
Apr.22
News
Resignation of Independent External Director of PHC Holdings Corporation
Apr.4
News
Resignation of Independent External Director of PHC Holdings Corporation
Jan.19
News
Changes in Corporate Officer Areas of Responsibility at PHC Holdings Corporation Effective January 19, 2022
Dec.23
PHC
Corporate
Announcement of New Assignment and Change in Role of Board Member at PHC Corporation Effective January 1, 2023
Dec.2
PHC
Corporate
Announcement of Resignation and New Appointment of a President at PHC Corporation Effective December 31, 2022 and January 1, 2023
Nov.8
Ascensia
Products
Ascensia Diabetes Care Announces Global Integration of The Eversense CGM System with Apple Health
Nov.3
Ascensia
Products
Senseonics and Ascensia Announce a Collaboration with the Nurse Practitioner Group Designed to Expand Patient Access by Providing In-Office and At-Home Insertion Options for Eversense
®
E3 Continuous Glucose Monitoring System (CGM)
Nov.2
Ascensia
Products
Ascensia Launches The GlucoContro.Online Diabetes Management and Analytics Platform in The U.S.
Oct.10
Ascensia
Products
Ascensia Diabetes Care Completes Initial European Launch of The Next-Generation Eversense E3 Continuous Glucose Monitoring System
Sep.27
Ascensia
Corporate
Ascensia Diabetes Care Relaunches Successful ‘This is Diabetes’ Competition in Support of IDF’s World Diabetes Day
Sep.12
Medicom
Products
Launch of Pilot Program Targeting Residents in Condominiums for an Online Medical Check-Up Program - Using Virtual Care Device Teladoc HEALTH and Activity Tracker MOTHER Bracelet
Sep.5
Epredia
Corporate
Epredia Expands Anatomical Pathology Business in Europe with Acquisition of Microm Microtech France and Laurypath
Aug.30
Epredia
Products
Epredia Launches Laser Cassette Printers Designed to Improve Sample Tracking and Laboratory Efficiency
Aug.8
PHC IVD
Products
PHC IVD and JCR Announces Upgraded Medication Management App Melon Nikki™ for Pediatric Patients Undergoing Growth Hormone Therapy
Jul.26
PHCbi
Products
PHCbi Develops First Prototype for Live Cell Metabolic Analysis, Paving the Way for Advances in Cell Therapy and Gene Therapy
Jun.27
PHC
Corporate
Announcement of Changes in Board Members at PHC Corporation Effective June 27, 2022
Jun.16
Ascensia
Products
Ascensia Diabetes Care Announces European Approval of the Next-Generation Eversense E3 Continuous Glucose Monitoring System
May.25
PHC
Corporate
Announcement of New Appointment of a Director at PHC Corporation Effective on June 27, 2022
May.2
Ascensia
Products
Ascensia Diabetes Care Presents New Research Showing that People Using the CONTOUR® Blood Glucose Monitoring System and App Experience Fewer Out-of-Target Blood Glucose levels
Apr.18
PHC IVD
Products
PHC Receives First EU-MDR Certification, Delivers Motorized Drug Injection Device Enabling More Efficient Patient-Friendly Treatment of Arthritis and Other Inflammatory Conditions
Apr.4
Ascensia
Products
Ascensia Diabetes Care Launches the 6 Month Eversense® E3 Continuous Glucose Monitoring System in the U.S. with the New Eversense Pass Savings Program
Mar.1
Ascensia
Products
Ascensia Diabetes Care Launches the Eversense® Now Remote Monitoring App for Android Users in Europe
Feb.14
Ascensia
Products
Ascensia Diabetes Care Announces FDA Approval of the Eversense E3 Continuous Glucose Monitoring System for Use for Up to 6 Months
Feb.14
Ascensia
Corporate
Ascensia Diabetes Care Proudly Supports Spare a Rose Campaign for Fifth Consecutive Year
2023
2022
2021
2020
2019
2018
2017
2016
2015